$240,000 of ACCENTURE FEDERAL SERVICES LLC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"FY26 Approps/ report language for key programs Army/ Air Force/ DOD IT/ logistics modernization; Cybersecurity FAFSA/ FSA/ student loan IT modernization Govt Efficiency/ IT modernization Healthcare IT modernization IRS/ Treasury IT modernization/ Digital Assets IT modernization/ Digital GI bill USDA/ Farmers.gov IT modernization Artificial Intelligence; Cybersecurity; Data Analytics; Legacy systems modernization"
You can find more data on corporate lobbying on Quiver Quantitative.
ACN Congressional Stock Trading
Members of Congress have traded $ACN stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 02/24.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/13.
- REPRESENTATIVE WILLIAM R. KEATING purchased up to $15,000 on 02/05.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 11/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ACN Insider Trading Activity
ACN insiders have traded $ACN stock on the open market 85 times in the past 6 months. Of those trades, 0 have been purchases and 85 have been sales.
Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:
- JULIE SPELLMAN SWEET (Chair and CEO) has made 0 purchases and 18 sales selling 28,426 shares for an estimated $10,684,913.
- JOEL UNRUCH (General Counsel/Corp Secretary) has made 0 purchases and 7 sales selling 9,500 shares for an estimated $3,480,562.
- MANISH SHARMA (CEO-The Americas) has made 0 purchases and 9 sales selling 8,311 shares for an estimated $3,112,914.
- JOHN F WALSH (Chief Operating Officer) has made 0 purchases and 7 sales selling 7,500 shares for an estimated $2,768,938.
- KATHLEEN R MCCLURE (Chief Financial Officer) has made 0 purchases and 3 sales selling 5,090 shares for an estimated $1,899,700.
- RYOJI SEKIDO (Co-CEO Asia Pacific) has made 0 purchases and 10 sales selling 4,891 shares for an estimated $1,767,190.
- MELISSA A BURGUM (Chief Accounting Officer) has made 0 purchases and 13 sales selling 2,177 shares for an estimated $789,660.
- MAURO MACCHI (Chief Executive Officer-EMEA) has made 0 purchases and 6 sales selling 2,000 shares for an estimated $726,673.
- ANGELA BEATTY (Chief Leadership & HR Officer) has made 0 purchases and 9 sales selling 2,009 shares for an estimated $725,557.
- ANGIE Y PARK (Chief Financial Officer) has made 0 purchases and 3 sales selling 685 shares for an estimated $242,753.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACN Hedge Fund Activity
We have seen 1,113 institutional investors add shares of ACN stock to their portfolio, and 942 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC added 3,410,248 shares (+30256.8%) to their portfolio in Q1 2025, for an estimated $1,064,133,785
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 2,830,387 shares (-86.5%) from their portfolio in Q4 2024, for an estimated $995,701,842
- WELLINGTON MANAGEMENT GROUP LLP added 2,260,740 shares (+22.8%) to their portfolio in Q4 2024, for an estimated $795,305,724
- BLACKROCK, INC. added 2,194,214 shares (+4.4%) to their portfolio in Q4 2024, for an estimated $771,902,543
- CAPITAL RESEARCH GLOBAL INVESTORS added 1,770,024 shares (+16.8%) to their portfolio in Q4 2024, for an estimated $622,676,742
- LEGAL & GENERAL GROUP PLC removed 1,455,773 shares (-23.3%) from their portfolio in Q4 2024, for an estimated $512,126,383
- BARCLAYS PLC removed 1,402,998 shares (-48.9%) from their portfolio in Q4 2024, for an estimated $493,560,666
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACN Analyst Ratings
Wall Street analysts have issued reports on $ACN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 03/08/2025
- Goldman Sachs issued a "Buy" rating on 12/19/2024
To track analyst ratings and price targets for ACN, check out Quiver Quantitative's $ACN forecast page.
ACN Price Targets
Multiple analysts have issued price targets for $ACN recently. We have seen 7 analysts offer price targets for $ACN in the last 6 months, with a median target of $385.0.
Here are some recent targets:
- An analyst from BMO Capital set a target price of $355.0 on 03/21/2025
- An analyst from Robert W. Baird set a target price of $390.0 on 03/17/2025
- Surinder Thind from Jefferies set a target price of $385.0 on 12/20/2024
- James Schneider from Goldman Sachs set a target price of $430.0 on 12/19/2024
- David Grossman from Stifel Nicolaus set a target price of $390.0 on 12/19/2024
- Stefan Slowinski from BNP Paribas set a target price of $375.0 on 10/30/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
